Supporting Children with Challenging Behaviours – Dr Andy Frey, University of Louisville

May 24, 2018education & training, social and behavioural sciences

Children with disruptive behaviours require intensive support in school. Dr Andy Frey, professor at the University of Louisville, has been developing and evaluating interventions that could help these children to begin their school years positively and successfully. The First Step Next and homeBase intervention programs involve a collaboration between parents and teachers to support children with problematic behavioural patterns achieve their potential.

[lbg_audio2_html5 settings_id=’77’]

You may also like …

Dr. Kendra Pugh | Mapping the Hidden Geography of Gambling Risk

A lottery ticket is small enough to slip into a pocket, but the forces that shape gambling behavior can stretch across families, neighborhoods, shopping districts, and entire communities. A Massachusetts study led by Dr. Kendra Pugh asks an important but deceptively simple question: when gambling becomes risky or problematic, how much depends on the person, and how much depends on the place?

Dr. Shimaa Ghazal | Reading the Mosquito: What Two New Genomes Can Tell Us About Malaria

A mosquito’s whine is easy to dismiss as a minor irritation. Yet some mosquitoes carry one of humanity’s oldest and deadliest diseases. Malaria is caused by microscopic Plasmodium parasites, but those parasites depend on Anopheles mosquitoes to move from one human host to another. Understanding the mosquito, therefore, is an important part of understanding the disease. Every new genetic reference gives researchers another way to investigate what makes these insects effective vectors, how populations differ, and how their biology may shape transmission. Two recent genome announcements involving Dr. Shimaa Ghazal and student researchers at Phillips Exeter Academy add new genetic resources for studying two particularly important malaria vectors: Anopheles gambiae and Anopheles stephensi.

Dr. Fay Betsou | The Hidden Life of a Biospecimen: Why Better Medical Research Begins Before the Laboratory Assay

To most of us, a vial of blood looks like a simple container of biological truth, a snapshot of what was happening inside a person at the moment the needle entered their arm. Scientists can measure its proteins, read genetic material, hunt for signs of disease, and feed the resulting data into increasingly powerful analytical systems. Yet that vial has a history. How long did it sit before processing? At what temperature? What kind of tube held it? Was it spun, transported, frozen, thawed, or stored? Each step may quietly change what researchers later believe they are seeing.

Prof. Shan Lu | Inducing Polyfunctional Antibodies: A Promising Chapter in the Long Search for an HIV Vaccine

For more than four decades, HIV has challenged some of the brightest scientific minds in the world. Tremendous progress has transformed HIV from what was once almost always a fatal infection into a condition that can often be managed with modern medicines. Preventive treatments have also become increasingly effective. Yet millions of people continue to become infected every year, particularly in regions where access to healthcare remains limited. A safe, effective preventive HIV vaccine remains one of the greatest goals in global medicine because it has the potential to provide large-scale, long-lasting prevention for large numbers of high-risk populations.

Prof. Dr. Daniel Gredig | Protection Is a Conversation: How Modern HIV Prevention Is Changing Intimacy and Trust

The story of HIV prevention has changed dramatically over the past four decades. What was once dominated by fear and limited options has become a field shaped by scientific breakthroughs, greater understanding, and a growing appreciation of personal choice. Yet while medicine has transformed the ways people can protect themselves, one element remains as important as ever. Prevention depends on communication. Every intimate encounter involves two people, each bringing their own experiences, expectations, and preferences. Reaching a shared understanding is rarely as simple as it appears.

Professor Thomas Münzel | Nicotine: The Molecule the Tobacco Industry Doesn’t Want You to Question

For decades, the story of tobacco and the heart seemed settled. Cigarettes were dangerous because they burned, releasing tar, carbon monoxide, and thousands of toxic chemicals that wrecked blood vessels. Remove the fire, the thinking went, and you remove almost all of the danger. That’s the logic behind heat-not-burn devices, e-cigarettes, and now nicotine pouches, each marketed, in turn, as the “safer” next step for people who can’t or won’t quit nicotine altogether.

Prof. Jean-Sébastien Delisle – Dr Mélanie Dieudé | The Medicine Is Ready. Is the Health System?

A medical breakthrough is only truly a breakthrough if it can reach the person who needs it. That simple idea sits at the heart of a rapidly growing challenge in cell therapy, gene therapy and regenerative medicine. These treatments are beginning to change what doctors can offer people with serious cancers, rare genetic conditions and other diseases once considered extraordinarily difficult to treat. Some therapies can reprogram a patient’s own cells to attack cancer. Others aim to repair or replace faulty biological instructions. Their promise can sound futuristic, yet the central problem is increasingly practical: how do we turn remarkable science into care that is affordable, timely and available to everyone who could benefit?

Prof. Yuben Moodley | Signals in the Scars: The Search for New Ways to Predict and Treat Lung Fibrosis

Breathing is so automatic that most of us notice it only when something goes wrong. Yet every breath depends on an extraordinarily delicate structure. Inside the lungs, tiny air sacs provide a vast, thin surface across which oxygen enters the blood. When that tissue is repeatedly injured, the body’s attempt to repair it can become part of the problem. Instead of restoring flexible lung tissue, repair processes may leave behind excessive scar tissue. As this fibrosis accumulates, the lungs become stiffer and less able to perform their essential task.

Prof. John Kopchick | Turning Off Cancer’s Growth Signal: The Unexpected New Life of a Growth Hormone Related Drug

When most of us hear “growth hormone,” we think of childhood, with bones lengthening, bodies developing, and the remarkable biological machinery that turns a small child into an adult. Growth hormone, or GH, deserves that reputation. Produced mainly by the pituitary gland, it helps regulate growth, metabolism, organ development and the production of another important messenger, insulin-like growth factor 1. Yet decades of research have revealed a more complicated story. The same signals that encourage healthy cells to grow and adapt can, in the wrong setting, help cancer cells survive.Because of these unanswered questions, researchers around the world continue searching for new ways to understand gravity. One intriguing contribution comes from Prof. Roberto Sussman and Dr. Sebastián Nájera of the National Autonomous University of Mexico, who have proposed a new gravity theory they denote as “Schouten–Codazzi Gravity”. Their work explores whether gravity might be described by a modified set of mathematical rules that remain closely connected to Einstein’s theory while opening the door to new possibilities.

Dr. Jerome Kim – Prof. Nicaise Ndembi | The future vaccine landscape: reaching more people with new technologies

For more than half a century, vaccines have quietly transformed human life. They have prevented suffering on a scale that is difficult to imagine, protecting millions of children from diseases that once claimed countless lives. Many of the most dramatic public health victories of the modern era have been built on vaccination. Diseases that once filled hospitals, overwhelmed families, and devastated communities became rare or disappeared entirely in many parts of the world. Yet vaccination now stands at a fascinating moment in history.